Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
Clinical trial NCT04968366 · COMPLETED
Trial details
- NCT number
- NCT04968366
- Sponsor
- Beijing Tiantan Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2024-04-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.